Cardiovascular Prevention for Persons With HIV

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

May 31, 2011

Conditions
HIV InfectionCardiovascular Disease Risk
Interventions
DRUG

Pravastatin

Participants randomized to take pravastatin (active) or matching placebo pill once daily

DRUG

Lisinopril

Participants randomized to take lisinopril (active) or matching placebo pill once daily

Trial Locations (1)

55415

Hennepin County Medical Center, Minneapolis

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Hennepin Healthcare Research Institute

OTHER